Functional dissection of Alzheimer’s disease brain gene expression signatures in humans and mouse models
暂无分享,去创建一个
Benjamin A. Logsdon | L. Tsai | Zhandong Liu | A. Levey | J. Shulman | L. Mangravite | H. Mei | M. Ehrlich | T. Dawson | V. Dawson | T. Golde | Ying-Wooi Wan | Minghui Wang | R. Al-ouran | C. Mangleburg | Tom V. Lee | Katherine S. Allison | S. Neuner | C. Kaczorowski | G. Howell | H. Martini-Stoica | Hui Zheng | Xiaoyan Zhong | P. Pao | Jean-Vianney Haure-Mirande | Paramita Chakrabarty | Y. Levites | Sarah M. Neuner | V. Phillip | J. Kim | B. Logsdon | H. Martini‐Stoica | Yona Levites | Zhandong Liu | Hongkang Mei | Vivek Phillip | Rami al-Ouran | Heidi Martini-Stoica | C. G. Mangleburg
[1] Hui Zheng,et al. Practical considerations for choosing a mouse model of Alzheimer’s disease , 2017, Molecular Neurodegeneration.
[2] J. Klappenbach,et al. Human Alzheimer’s disease gene expression signatures and immune profile in APP mouse models: a discrete transcriptomic view of Aβ plaque pathology , 2018, Journal of Neuroinflammation.
[3] C. Jack,et al. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers , 2013, The Lancet Neurology.
[4] Jeffrey H. Chuang,et al. Activation of GCN2 kinase by ribosome stalling links translation elongation with translation initiation , 2016, eLife.
[5] James A. Eddy,et al. Human whole genome genotype and transcriptome data for Alzheimer’s and other neurodegenerative diseases , 2016, Scientific Data.
[6] Cory C. Funk,et al. Conserved brain myelination networks are altered in Alzheimer's and other neurodegenerative diseases , 2018, Alzheimer's & Dementia.
[7] T. Wisniewski,et al. Alzheimer’s disease: experimental models and reality , 2017, Acta Neuropathologica.
[8] M. Block,et al. Microglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanism , 2005, Progress in Neurobiology.
[9] Geoffrey E. Hinton,et al. Visualizing Data using t-SNE , 2008 .
[10] James A. Eddy,et al. Meta-analysis of the human brain transcriptome identifies heterogeneity across human AD coexpression modules robust to sample collection and methodological approach , 2019, bioRxiv.
[11] Eric Karran,et al. The Cellular Phase of Alzheimer’s Disease , 2016, Cell.
[12] C. Ross,et al. Protein aggregation and neurodegenerative disease , 2004, Nature Medicine.
[13] F. Edwards,et al. A genome-wide gene-expression analysis and database in transgenic mice during development of amyloid or tau pathology. , 2015, Cell reports.
[14] Manolis Kellis,et al. Conserved epigenomic signals in mice and humans reveal immune basis of Alzheimer’s disease , 2015, Nature.
[15] J. Götz,et al. Animal models of Alzheimer's disease and frontotemporal dementia , 2008, Nature Reviews Neuroscience.
[16] Li-Huei Tsai,et al. Aberrant Cdk5 Activation by p25 Triggers Pathological Events Leading to Neurodegeneration and Neurofibrillary Tangles , 2003, Neuron.
[17] A. Nógrádi,et al. Severely dystrophic axons at amyloid plaques remain continuous and connected to viable cell bodies. , 2009, Brain : a journal of neurology.
[18] D. Selkoe. Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.
[19] Bin Zhang,et al. Multiscale network modeling of oligodendrocytes reveals molecular components of myelin dysregulation in Alzheimer’s disease , 2017, Molecular Neurodegeneration.
[20] Salvador Ventura,et al. Protein misfolding diseases , 2015, Future science OA.
[21] Reductions in hypothalamic Gfap expression, glial cells and α-tanycytes in lean and hypermetabolic Gnasxl-deficient mice , 2016, Molecular Brain.
[22] A. Plagge,et al. Elevated blood pressure, heart rate and body temperature in mice lacking the XLαs protein of the Gnas locus is due to increased sympathetic tone , 2013, Experimental physiology.
[23] Matthew E. Ritchie,et al. limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.
[24] Andre Altmann,et al. Sex modifies the APOE‐related risk of developing Alzheimer disease , 2014, Annals of neurology.
[25] C. Dobson,et al. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases , 2002, Nature.
[26] H. Kornblum,et al. Interactive Regulation of Neuronal Development by Hippocampal Stem Cell Niche Populations , 2019, Neuron.
[27] Madhav Thambisetty,et al. A Multi-network Approach Identifies Protein-Specific Co-expression in Asymptomatic and Symptomatic Alzheimer's Disease. , 2017, Cell systems.
[28] Xia Yang,et al. Common dysregulation network in the human prefrontal cortex underlies two neurodegenerative diseases , 2014 .
[29] T. Iwaki,et al. Comparative profiling of cortical gene expression in Alzheimer’s disease patients and mouse models demonstrates a link between amyloidosis and neuroinflammation , 2017, Scientific Reports.
[30] Nick C Fox,et al. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease , 2017, Nature Genetics.
[31] K. Blennow,et al. Alzheimer's disease , 2016, The Lancet.
[32] D. Lomas,et al. Endoplasmic reticulum dysfunction in neurological disease , 2013, The Lancet Neurology.
[33] P. Hof,et al. The isotropic fractionator provides evidence for differential loss of hippocampal neurons in two mouse models of Alzheimer's disease , 2012, Molecular Neurodegeneration.
[34] Thomas R. Gingeras,et al. STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..
[35] J. Güell-Bosch,et al. Mouse Models of Alzheimer's Disease. , 2017, Journal of Alzheimer's disease : JAD.
[36] B. Winblad,et al. APP mouse models for Alzheimer's disease preclinical studies , 2017, The EMBO journal.
[37] Nick C Fox,et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease , 2013, Nature Genetics.
[38] W. Huber,et al. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.
[39] G. Howell,et al. Toward more predictive genetic mouse models of Alzheimer's disease , 2016, Brain Research Bulletin.
[40] K. Ashe,et al. Age-Dependent Neurofibrillary Tangle Formation, Neuron Loss, and Memory Impairment in a Mouse Model of Human Tauopathy (P301L) , 2005, The Journal of Neuroscience.
[41] R. Leite,et al. Transcriptomic analysis of purified human cortical microglia reveals age-associated changes , 2017, Nature Neuroscience.
[42] J. Trojanowski,et al. Tau-mediated neurodegeneration in Alzheimer's disease and related disorders , 2007, Nature Reviews Neuroscience.
[43] G. Smyth,et al. ROBUST HYPERPARAMETER ESTIMATION PROTECTS AGAINST HYPERVARIABLE GENES AND IMPROVES POWER TO DETECT DIFFERENTIAL EXPRESSION. , 2016, The annals of applied statistics.
[44] Tim Clark,et al. Tau induces blood vessel abnormalities and angiogenesis-related gene expression in P301L transgenic mice and human Alzheimer’s disease , 2018, Proceedings of the National Academy of Sciences.
[45] Andrew H. Chiang,et al. Protein Misfolding Diseases. , 2017, Annual review of biochemistry.
[46] A. Goate,et al. Alzheimer’s Disease Genetics: From the Bench to the Clinic , 2014, Neuron.
[47] A. Blockeel,et al. Tracking progressive pathological and functional decline in the rTg4510 mouse model of tauopathy , 2017, Alzheimer's Research & Therapy.
[48] Paul Theodor Pyl,et al. HTSeq—a Python framework to work with high-throughput sequencing data , 2014, bioRxiv.
[49] David A Bennett,et al. Religious Orders Study and Rush Memory and Aging Project. , 2018, Journal of Alzheimer's disease : JAD.
[50] Alexander A. Morgan,et al. Mouse models rarely mimic the transcriptome of human neurodegenerative diseases: A systematic bioinformatics-based critique of preclinical models. , 2015, European journal of pharmacology.
[51] Gonçalo R. Abecasis,et al. The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..
[52] C. Reitz. Novel susceptibility loci for Alzheimer's disease. , 2015, Future neurology.
[53] L. Tran,et al. Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease , 2013, Cell.
[54] Benjamin A. Logsdon,et al. The Mount Sinai cohort of large-scale genomic, transcriptomic and proteomic data in Alzheimer's disease , 2018, Scientific Data.
[55] S. Amor,et al. Inflammation in CNS neurodegenerative diseases , 2018, Immunology.
[56] M. Huentelman,et al. Harnessing Genetic Complexity to Enhance Translatability of Alzheimer’s Disease Mouse Models: A Path toward Precision Medicine , 2019, Neuron.
[57] Sean R. Davis,et al. GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductor , 2007, Bioinform..
[58] D. Selkoe,et al. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide , 2007, Nature Reviews Molecular Cell Biology.
[59] T. Maniatis,et al. An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex , 2014, The Journal of Neuroscience.
[60] F. Edwards,et al. First effects of rising amyloid-β in transgenic mouse brain: synaptic transmission and gene expression , 2015, Brain : a journal of neurology.
[61] C. Moriconi,et al. Neuroserpin polymers cause oxidative stress in a neuronal model of the dementia FENIB , 2017, Neurobiology of Disease.
[62] Sven Rahmann,et al. Snakemake--a scalable bioinformatics workflow engine. , 2012, Bioinformatics.
[63] Huihao Zhou,et al. Ribosome stalling induced by mutation of a CNS-specific tRNA causes neurodegeneration , 2014, Science.
[64] Rena Li,et al. Sex differences in cognitive impairment and Alzheimer’s disease , 2014, Frontiers in Neuroendocrinology.
[65] X. Yao,et al. Sex Dimorphism Profile of Alzheimer’s Disease-Type Pathologies in an APP/PS1 Mouse Model , 2015, Neurotoxicity Research.
[66] R. Mayeux,et al. Epidemiology of Alzheimer disease. , 2012, Cold Spring Harbor perspectives in medicine.
[67] Frank M LaFerla,et al. Animal models of Alzheimer disease. , 2012, Cold Spring Harbor perspectives in medicine.
[68] Charles C. White,et al. A molecular network of the aging human brain provides insights into the pathology and cognitive decline of Alzheimer’s disease , 2018, Nature Neuroscience.
[69] V. Lee,et al. Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases , 2014, Nature Medicine.
[70] Nicholas E. Propson,et al. Concurrent cell type-specific isolation and profiling of mouse brains in inflammation and Alzheimer's disease. , 2018, JCI insight.
[71] R. Nixon. Endosome function and dysfunction in Alzheimer's disease and other neurodegenerative diseases , 2005, Neurobiology of Aging.
[72] Galina A. Erikson,et al. The Aging Astrocyte Transcriptome from Multiple Regions of the Mouse Brain , 2018, Cell reports.
[73] E. Blalock,et al. Transcriptional signatures of brain aging and Alzheimer’s disease: What are our rodent models telling us? , 2017, Behavioural Brain Research.
[74] C. DeCarli,et al. Impact of multiple pathologies on the threshold for clinically overt dementia , 2017, Acta Neuropathologica.
[75] Anne-Laure Boulesteix,et al. Regularized estimation of large-scale gene association networks using graphical Gaussian models , 2009, BMC Bioinformatics.
[76] S. Lovestone,et al. NRF2 deficiency replicates transcriptomic changes in Alzheimer's patients and worsens APP and TAU pathology , 2017, Redox biology.